Innate Defense against Fungal Pathogens

  1. Gordon D. Brown1
  1. 1Aberdeen Fungal Group, University of Aberdeen, Aberdeen AB25 2ZD, United Kingdom
  2. 2Department of Medicine, Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania 15261
  3. 3Department of Pathology, Case Western Reserve University, School of Medicine, Cleveland, Ohio 44106
  4. 4Department of Medicine, Louis Stokes Veterans Affairs Medical Centre, Cleveland, Ohio 44106
  1. Correspondence: r01rad0{at}abdn.ac.uk

Abstract

Human fungal infections have been on the rise in recent years and proved increasingly difficult to treat as a result of the lack of diagnostics, effective antifungal therapies, and vaccines. Most pathogenic fungi do not cause disease unless there is a disturbance in immune homeostasis, which can be caused by modern medical interventions, disease-induced immunosuppression, and naturally occurring human mutations. The innate immune system is well equipped to recognize and destroy pathogenic fungi through specialized cells expressing a broad range of pattern recognition receptors (PRRs). This review will outline the cells and PRRs required for effective antifungal immunity, with a special focus on the major antifungal cytokine IL-17 and recently characterized antifungal inflammasomes.

Also in this Collection

    | Table of Contents

    Richard Sever interviews Joan Brugge